Evidence map›Paper›PMID 41933004›Full record

ArticleScientific reports2026

A diffusion model conditioned on compound bioactivity profiles for generating high-content images.

Steven Cook, Jason Chyba, Laura Gresoro, Doug Quackenbush, Minhua Qiu, Peter Kutchukian, Eric J Martin, Peter Skewes-Cox, William J Godinez

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Steven CookNovartis Biomedical Research, San Diego, 92121, CA, USA. steven-1.cook@novartis.com.
Jason ChybaNovartis Biomedical Research, San Diego, 92121, CA, USA.
Laura GresoroNovartis Biomedical Research, San Diego, 92121, CA, USA.
Doug QuackenbushNovartis Biomedical Research, San Diego, 92121, CA, USA.
Minhua QiuNovartis Biomedical Research, San Diego, 92121, CA, USA.
Peter KutchukianNovartis Biomedical Research, Cambridge, 02139, MA, USA.
Eric J MartinNovartis Biomedical Research, Emeryville, 94608, CA, USA.
Peter Skewes-CoxNovartis Biomedical Research, Emeryville, 94608, CA, USA.
William J GodinezNovartis Biomedical Research, Emeryville, 94608, CA, USA. william_jose.godinez_navarro@novartis.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-content imaging (HCI) provides a rich snapshot of compound-induced phenotypic outcomes that augment our understanding of how compounds affect cellular systems. Generative imaging models for HCI provide a route towards anticipating the phenotypic outcomes of chemical perturbations in silico at unprecedented scale and speed. Here, we developed Profile-Diffusion (pDIFF), a generative method leveraging a profile-to-image latent diffusion model conditioned on in silico bioactivity profiles to generate high-content images displaying the cellular outcomes induced by compound treatment. We trained and evaluated a pDIFF model using high-content images from a Cell Painting assay profiling 3750 molecules (3375 training compounds and 375 held-out compounds) with corresponding in silico bioactivity profiles. Using the held-out set we demonstrate that pDIFF provides improved visual depictions of phenotypic responses of compounds that are structurally dissimilar to training compounds, compared to a baseline profile-to-image latent diffusion model trained on substructural molecular descriptors only. In a virtual hit expansion scenario, pDIFF yielded statistically significant improvement in expansion outcomes as measured by nearest-neighbor retrieval accuracy, compared to expansions based on compound structural representations, bioactivity profiles, and generative imaging models based only on substructural molecular descriptors, thus showcasing the potential of the methodology to speed up and improve the search for novel phenotypically active molecules.

Indexed as

Drug DiscoveryComputer SimulationGenerative Artificial IntelligenceHumansGenerative AI for drug discoveryIn silico HCIVirtual screening

Identifiers

PMID41933004
PMCPMC13199470

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.